(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Division of Pathology is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty.
David P. Witte, MD Director, Pathology 513-636-4261 email@example.com
Director, Mass Spectrometry Laboratory
Professor, UC Department of Pathology & Laboratory Medicine
Molecular pathology; pediatric renal pathology
MD: University of Cincinnati, Cincinnati, OH, 1979.
Residency: Pediatrics, Washington University, St. Louis, MO, 1979-1980; Pathology, Washington University, St. Louis, MO, 1980-1984.
Fellowship: Pathology, Children's Hospital Medical Center, Cincinnati, OH, 1984-1986; Research Scholar, Pathology, Children's Hospital Medical Center, Cincinnati, OH, 1986-1989.
Certification: Anatomic Pathology, American Board of Pathology, 1985; Pediatric Pathology, American Board of Pathology, 1991.
Michael Baker, MD 513-636-4261 firstname.lastname@example.org
Assistant Professor, UC Department of Pathology & Laboratory Medicine
Undergraduate: Louisiana State University, Baton Rouge, LA.
Medical School: Louisiana State University Medical Center, Baton Rouge, LA.
AP/CP Residency: Dartmouth Hitchcock Medical Center, Lebanon, NH.
Pediatric Pathology: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Certifications: Anatomic/Clinical/Pediatric Pathology.
Kevin E. Bove, MD 513-636-4261 email@example.com
Professor, UC Department of Pediatrics
UC Department of Pathology & Laboratory Medicine
Dr. Bove has been a career academic pediatric pathologist at Cincinnati Children's since 1968. He functions as a surgical pathologist, autopsy consultant and electron microscopist with diverse clinical interests. His collaborations with faculty and fellows in many divisions have resulted in more than 180 peer-reviewed and more than 120 publications.
Kevin E. Bove, MD, has 32 years experience as a pediatric pathologist at Cincinnati Children's Hospital Medical Center.
Dr. Bove has achieved national recognition as an expert in tumors; neuromuscular diseases; liver diseases of children and performance / interpretation of pediatric autopsies.
Dr. Bove has and continues to be involved in leadership positions in the Society for Pediatric Pathology and the College of American Pathologists.
MD: State University of New York, Buffalo, NY.
Residency: Rotating Intern, Cincinnati General Hospital, 1961-1962; Pathology, Cincinnati General Hospital, 1962-1966.
Certification: American Board of Pathology in Anatomic and Clinical Pathology, 1967 and 1968; Pediatric Pathology, 1990.
Margaret H. Collins, MD 513-636-4261 firstname.lastname@example.org
Pediatric gastrointestinal pathology; eosinophilic gastrointestinal diseases; biopsy analyses; primary study endpoints; novel therapies to treat eosinophilic esophagitis in children; disorders of bowel immunity; bowel motility disorders
BS: Fordham University, NY, 1972.
MD: Georgetown University, Washington, D.C., 1977.
Residency: Pathology, New York Hospital, NY, 1977-80; Pathology, Columbia-Presbyterian Medical Center, NY, 1980-83.
Fellowship: Research, New York Lung Association, Columbia-Presbyterian Medical Center, N.Y., 1983-85; Research, American Lung Association, Columbia-Presbyterian Medical Center, NY, 1985-87.
Certification: Pathology, 1981; Pediatric Pathology, 1991.
Nikolaidis NM, Kulkarni RM, Gray JK, Collins MH, Waltz SE. Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate Immun. 2010 Nov 18.
Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Assa'ad AH, Kovacic MB, Biagini Myers JM, Bochner BS, He H, Hershey GK, Martin LJ, Rothenberg ME. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol. 2010 Jul;126(1):160-5.e3.
DeBrosse CW, Collins MH, Buckmeier Butz BK, Allen CL, King EC, Assa'ad AH, Abonia JP, Putnam PE, Rothenberg ME, Franciosi JP. Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol. 2010 Jul;126(1):112-9.
Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer K, Putnam PE, Rothenberg ME. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol. 2010 Jul;126(1):140-9.
Caldwell JM, Blanchard C, Collins MH, Putnam PE, Kaul A, Aceves SS, Bouska CA, Rothenberg ME. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol. 2010 Apr;125(4):879-888.e8.
Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, Gober L, Kim C, Glessner J, Frackelton E, Thomas K, Blanchard C, Liacouras C, Verma R, Aceves S, Collins MH, Brown-Whitehorn T, Putnam PE, Franciosi JP, Chiavacci RM, Grant SF, Abonia JP, Sleiman PM, Hakonarson H. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010 Apr;42(4):289-91.
Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, Buckmeier BK, Jameson SC, Greenberg A, Kaul A, Franciosi JP, Kushner JP, Martin LJ, Putnam PE, Abonia JP, Wells SI, Rothenberg ME. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010 Apr 1;184(7):4033-41.
Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, Hegde RS, Cripe TP, Cancelas JA, Collins MH, Ratner N. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene. 2010 Jan 21;29(3):368-79.
Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, Putnam PE, Abonia JP, Santos J, Rothenberg ME. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut. 2010 Jan;59(1):12-20.
Prosperi JR, Becher KR, Willson TA, Collins MH, Witte DP, Goss KH. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland. J Cell Physiol. 2009 Aug;220(2):319-31.
Christine Fuller, MD 513-636-4261
Neuropathology; pediatric brain tumors; genetic basis of brain tumors.
As a board-certified neuropathologist, Dr. Fuller's primary area of expertise is in the gross and microscopic presentations of a wide variety of nervous system diseases. Through her clinical work and numerous collaborative projects, she's had the opportunity to examine thousands of brain tissue samples from both human and various rodent models.
Dr. Fuller has authored and co-authored numerous peer-reviewed articles in scientific journals (case reports and series, and basic and translational research), as well as multiple review articles, book chapters, and an atlas on a variety of brain neoplasms and other neuropathologic entities. She has in the past and now continue to be a part of large group translational collaborations that help provide crucial insight into the molecular alterations and potential therapeutic targets involved in the tumorigenesis of gliomas, ependymomas, and CNS embryonal tumors. Dr. Fuller has expertise in novel fluorescence in situ hybridization (FISH) probe development and evaluation for gene copy number alterations, and she has broad knowledge of a variety of molecular techniques aimed at the genetic characterization of neoplasms. Lastly, Dr. Fuller has broad administrative experience, serving as both clinical director of Autopsy and Neuropathology at VCU, as well as residency program director and neuropathology fellowship director at that same institution.
MD: SUNY Upstate Medical University, Syracuse, NY, 1995.
Residency: Anatomic and Clinical Pathology, SUNY Upstate Medical University, Syracuse, NY, 1999.
Fellowships: Surgical Pathology, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, MO, 2000; Neuropathology, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, MO, 2002.
Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emdad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB. MDA-9/Syntenin is a key regulator of glioma pathogenesis. Neuroonc. 2014;16(1):50-61.
Broniscer A, Baker SJ, West AN, Fraser MM, Kocak M, Dalton J, Zambetti GP, Gajjar A, Gilbertson RJ, Fuller CE. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children: the St. Jude Children’s Research Hospital experience. J Clin Oncol. 2007;25:682-689.
Thompson MC, Fuller C, Hogg T, Dalton J, Finkelstein D, Lau C, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol. 2006;24(12):1924-31.
Taylor MD, Poppleton H, Fuller C, Su X, Liu X, Jensen P, Magdelano S, Dalton J, Board J, MacDonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell. 2005;8:323-335.
Tekautz T, Fuller C, Fouladi M, Broniscer A, Merchant T, Krasin M, Dalton J, Hale G, Kun L, Wallace D, Gilbertson R, Gajjar A. Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol. 2005;23(7):1491-9.
Romer J, Kimura H, Magdaleno S, Fuller C, Baines H, Connelly M, Gould S, Rubin L, Curran T. Suppression of the Shh pathway using a small molecular inhibitor eliminates medulloblastoma in Ptc+/- p53-/- mice. Cancer Cell. 2004;6(3):229-240.
Gajjar A, Hernan R, Kocak M, Fuller CE, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley D, Kellie S, Kun L, Gilbertson R. Clinical, histopathological and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22(6):984-93.
Fuller CE, Schmidt RE, Roth KA, Burger PC, Scheithauer BW, Banerjee R, Trinkaus K, Lytle R, Perry A. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol. 2003;62(11):1118-1128.
Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: Utility of fluorescence in-situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol. 2002;61(12):1078-1084.
Fuller CE, Pfeifer J, Humphrey P, Bruch LA, Dehner LP, Perry A. Chromosome 22 alterations in composite extrarenal rhabdoid tumors: Clonal evolution or a phenotypic mimic? Hum Pathol. 2001;32:1102-1108.
Anita Gupta, MD 513-636-4261 email@example.com
Associate Professor, UC Department of Pediatrics
UC Department of Pathology and Laboratory Medicine
Pediatric pathology; surgical pathology; electron microscopy.
MD: Mahadevappa Rampure Medical College, Gulbarga, Karnataka, India, 1997.
Residency: Northwestern Memorial Hospital, Chicago, IL, 2001-2005.
Fellowship: The Children's Hospital, Denver, CO, 2006.
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011 Dec 1;57 (6):1018-24
Maugans T, Sheridan RM, Adams D, Gupta A. Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited. Neurosurgery. 2011 Jul;69(1):112-8
Gupta A, Kozakewich H. Histopathology of vascular anomalies. Clin Plast Surg. 2011 Jan;38(1):31-44.
Bischoff A, Gupta A, D'Mello S, Mezoff A, Podberesky D, Barnett S, Keswani S, Frischer JS. Crohn's disease limited to the appendix: a case report in a pediatric patient. Pediatr Surg Int. 2010 Nov;26(11):1125-8.
Stevenson CB, Leach JL, Gupta A, Crone KR. Cystic degeneration of the cerebellar tonsils in pediatric patients with Chiari Type I malformation. J Neurosurg Pediatr. 2009 Dec;4(6):557-63.
Zynger DL, Gupta A, Luan C, Chou PM, Yang GY, Yang XJ. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol. 2008; 39 (2):224-30.
Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ. Expression of Kidney-Specific Cadherin in Chromophobe Renal Cell Carcinoma. Am J Clin Pathol. 2006 Jul; 126(1): 79-85.
Blecha MJ, Gupta A, Hoover JD, Madonna MB. Chronic abdominal pain secondary to a mucous cystadenoma of the appendix in a 10-year-old boy. J Pediatr Surg. 2005 Nov; 40(11): 1792-4.
Salanitri G, Huo E, Miller F, Gupta A, Pereles S. MRI of Mycotic Sinus of Valsalva Pseudoaneurysm Secondary to Aspergillus Pericarditis. Amer J Roentgenology. 2005; 184: S25-S27
Gupta A, Madallozo J, Win Htin T, Shah A, Chou PM. Spindle cell rhabdomyosarcoma of the tongue in an infant. Pathol Research and Practice. 2004; 200: 537-543.
Richard L. McMasters, MD Staff Pathologist, Division of Pathology and Laboratory Medicine 513-636-4261 firstname.lastname@example.org
Staff Pathologist, Division of Pathology and Laboratory Medicine
Assistant Professor, UC Department of Pediatrics
Childhood leukemia, lymphoma and bone marrow failure syndrome; applications of flow cytometry in the diagnosis and management of these disorders.
MD: Baylor College of Medicine, Houston, TX, 1994.
Residency: Harbor-UCLA Medical Center, Torrance, CA, 2002.
Fellowships: Children's Hospital Los Angeles, Los Angeles, CA, 2003; LAC-USC Medical Center, Los Angeles, CA, 2004; Akron Children's Hospital, Akron, OH, 2005.
Certification: Anatomic and Clinical Pathology, 2003; Hematology (Pathology), 2004; Pediatric Pathology, 2005.
Joel E. Mortensen, PhD Director, Diagnostic Infectious Diseases Testing Laboratory (Microbiology and Virology) 513-636-5310 email@example.com
Director, Diagnostic Infectious Diseases Testing Laboratory (Microbiology and Virology)
Application of rapid testing methods into the clinical microbiology laboratory and outpatient settings; LEAN manufacturing processes applied to clinical microbiology.
Dr. Mortensen is a career academic clinical microbiologist in the Department of Pathology and Laboratory Medicine at Cincinnati Children's since 1991. Beyond providing consultation to the medical staff in clinical microbiology, his clinical interests include the application of rapid testing methods into the clinical microbiology laboratory and outpatient settings and LEAN manufacturing processes applied to clinical microbiology. His collaborations with faculty and fellows have resulted in more than 100 peer-reviewed publications, case studies and text chapters.
BS: Mount Union College, Alliance, OH, 1979.
PhD: The Ohio State University, Columbus, OH, 1983.
Residency: Accredited Postdoctoral Residence Program in Medical and Public Health Microbiology; Baylor College of Medicine, University of Texas Medical School, Pathology, Houston, TX, 1983-85.
Certification: Certified Laboratory Consultant, American Medical Technologists, 1998.
Motley WW, Melson AT, Mortensen JE. Pediatric Metarhizium anisopliae keratitis. J AAPOS. 2011 Feb 10.
Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob Agents Chemother. 2010 Nov;54(11):4671-7.
Chhabra MS, Motley WW 3rd, Mortensen JE. Eikenella corrodens as a causative agent for neonatal conjunctivitis. J AAPOS. 2008 Oct;12(5):524-5.
Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Hobbs MM. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis. 2008 Mar;35(3):250-4.
Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, Hobbs MM. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis. 2007 Jul 15;45(2):194-8.
Huppert JS, Biro F, Lan D, Mortensen JE, Reed J, Slap GB. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health. 2007 May;40(5):418-24.
Iyer SB, Gerber MA, Pomerantz WJ, Mortensen JE, Ruddy RM. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med. 2006 Dec;13(12):1259-68.
Huppert JS, Gerber MA, Deitch HR, Mortensen JE, Staat MA, Adams Hillard PJ. Vulvar ulcers in young females: a manifestation of aphthosis. J Pediatr Adolesc Gynecol. 2006 Jun;19(3):195-204.
Mortensen JE, Gerrety MJ, Gray LD. Surveillance of antimicrobial resistance in Neisseria meningitidis from patients in the Cincinnati Tri-State region (Ohio, Kentucky, and Indiana). J Clin Microbiol. 2006 Apr;44(4):1592-3.
Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang SH, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest. 2006 Feb;116(2):436-46.
Lindsey E. Romick-Rosendale, PhD Director, Metabolomics Core Facility, Mass Spectrometry Laboratory, Division of Pathology and Laboratory Medicine 513-803-2765 firstname.lastname@example.org
Director, Metabolomics Core Facility, Mass Spectrometry Laboratory, Division of Pathology and Laboratory Medicine
Field Service Assistant Professor, UC Department of Pathology & Laboratory Medicine
BS: Chemistry, Marietta College, Marietta, OH, 2007.
PhD: Chemistry with concentration in biological chemistry, Miami University, Oxford, OH, 2011.
Romick-Rosendale LE, Lui VWY, Grandis JR, Wells SI. The Fanconi anemia pathway: Repairing the link between DNA damage and squamous cell carcinoma. Mutat Res. 2013 Mar-Apr; 743-744:78-88.
Romick-Rosendale LE, Lagomarcino AJ, Patel NB, Taft D, Morrow AL, Kennedy MA. Prolonged antibiotic use induces intestinal injury in mice that is repaired after removing antibiotic pressure: Implications for empiric antibiotic therapy. Metabolomics. 2014 10;1:8-20.
Romick-Rosendale LE, Schibler KR, Kennedy MA. A potential biomarker for acute kidney injury in preterm infants from metabolic profiling. J Mol Biomark Diagn. 2012 S3:001.
Romick-Rosendale LE, Brunner HI, Bennett MR, Mina R, Nelson S, Petri M, Kiani A, Kiani A, Devarajan P, Kennedy MA. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis. Arthritis Res Ther. 2011;13(6)R199.
Goodpaster AM, Romick-Rosendale LE, Kennedy MA. Statistical significance analysis of nuclear magnetic resonance-based metabonomics data. Anal Biochem. 2010 Jun 1;401(1):134-143.
Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, Patel NB, Wheeler ET, Chona DL, Kennedy MA. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem. 2009 Dec;47 Suppl 1:S36-46.
Kenneth D. Setchell, PhD Director, Mass Spectrometry Lab 513-636-4548 email@example.com
Director, Mass Spectrometry Lab
Kenneth D. Setchell, PhD, joined the tenured faculty of the Department of Pediatrics, University of Cincinnati College of Medicine in 1984, having moved from the Clinical Research Centre of the Medical Research Council, (UK) where he previously held a tenured scientific position. In 1973 he obtained a PhD in steroid biochemistry from the University of London. He was then awarded a fellowship from The Royal Society for post-doctoral studies at the Karolinska Institute in Stockholm, Sweden (1974-1975) in the application of mass spectrometry to clinical and biomedical problems specifically relating to the steroid hormone field. He returned to the United Kingdom to a scientific position in the Division of Clinical Chemistry at the Medical Research Council's Clinical Research Centre where he continued his research in the field of steroids, expanding into cholesterol and bile acid metabolism as it related to gastrointestinal diseases. His parallel research discoveries of the first mammalian lignans later led to the discovery of soy isoflavones in humans, their association with soy intake, and established his research in the area of bioactive plant constituents and human nutrition and disease.
In September 1984, Dr. Setchell moved to Cincinnati to become director of a new Clinical Mass Spectrometry facility at Cincinnati Children's Hospital Medical Center, and he is now a tenured professor in the Department of Pediatrics at the UC College of Medicine. His research program is internationally recognized as a leader in several areas of research that established collaborations with other groups from England, Italy, Germany, France Sweden, Canada and Australia. He has consulted with pharmaceutical and food companies, and to industries involved in clinical and biochemical research. Dr. Setchell cites >200 scientific publications and has presented over 250 papers at national and international symposia, while serving on national and international committees and editorial boards of international journals. Dr. Setchell was awarded the 1997 Gilbride award by the Canadian Liver Foundation for his contributions to the diagnosis and treatment of liver disease. He received awards from the AOCS at the 3rd International Symposium on the "Role of Soy in Preventing and Treating Chronic Disease" in 1999 for his outstanding contributions to increasing understanding and awareness of the health benefits of soy foods and soybean constituents, and from North American Menopause Society (NAMS) 2000 annual award for his research on soy and women's health. He received the Roche 2003 International Award for Innovative Research in Human Nutrition for his discoveries of classes of phytoestrogens and the 2004 Adolf Windaus Prize for research on bile acids and the discovery of genetic defects in the cholesterol-bile acid pathway causing liver disease.
Some of his most significant research contributions include the following:
Shiva K. Shanmukhappa, DVM, PhD, Diplomate ACVP 513-803-4289 firstname.lastname@example.org
Liver repair and regeneration; NASH; metabolic complication of HIV; sickle cell disease; nephropathy.
Shiva Kumar Shanmukhappa joined the Cincinnati Children's Division of Pathology and Laboratory Medicine in 2012 as an assistant professor within the UC Department of Pathology and Laboratory Medicine overseeing the research pathology core.
From 2009-2012, Dr. Shanmukhappa was a comparative pathology fellow in the Division of Comparative Pathology, New England Primate Research Center, Harvard Medical School.
Dr. Shanmukhappa was a research fellow in the Division of Gastroenterology, Hepatology and Nutrition from 2003 to 2009 where he primarily worked on understanding the molecular mechanism involved in liver repair and regeneration as well as the induction of pancreatic cells in liver during defective liver repair. He identified the role of plasmin in liver repair. He has shown that plasmin mediates liver repair through the activation of HGF-MET signaling mainly affecting cell motility.
Dr. Shanmukhappa has an active research career with his primary interests in molecular control of liver repair, regeneration, biliary atresia, NASH and metabolic complications of HIV.
DVM: Veterinary College, University of Agricultural Sciences, Bangalore, India,1996.
PhD: Department of Veterinary Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, 2002.
Residency: Comparative Pathology, New England Primate Research Center, Harvard Medical School, Southborough, MA.
Certification: Veterinary Anatomic Pathology, 2013.
Bessho K, Shanmukhappa K, Sheridan R, Shivakumar P, Mourya R, Walters S, Kaimal V, Dilbone E, Jegga AG, Bezerra JA. Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia. BMC Syst Biol. 2013 Oct 20;7:104.
Marzioni M, Saccomanno S, Agostinelli L, Rychlicki C, De Minicis S, Pierantonelli I, Trauner M, Fickert P, Müller T, Shanmukhappa K, Trozzi L, Candelaresi C, Baroni GS, Benedetti A. PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis. J Hepatol. 2013 Apr;58(4):750-6.
Sasseville VG, Mansfield KG, Mankowski JL, Tremblay C, Terio KA, Mätz-Rensing K, Gruber-Dujardin E, Delaney MA, Schmidt LD, Liu D, Markovits JE, Owston M, Harbison C, Shanmukhappa SK, Miller AD, Kaliyaperumal S, Assaf BT, Kattenhorn L, Macri SC, Simmons HA, Baldessari A, Sharma P, Courtney C, Bradley A, Cline JM, Reindel JF, Hutto DL, Montali RJ, Lowenstine LJ. Meeting report: Spontaneous lesions and diseases in wild, captive-bred, and zoo-housed nonhuman primates and in nonhuman primate species used in drug safety studies. Vet Pathol. 2012 Nov;49(6):1057-69.
Sheridan R, Lampe K, Shanmukhappa SK, Putnam P, Keddache M, Divanovic S, Bezerra J, Hoebe K. Lampe1: an ENU-germline mutation causing spontaneous hepatosteatosis identified through targeted exon-enrichment and next-generation sequencing. PLoS One. 2011;6(7):e21979.
Mann EA, Shanmukhappa K, Cohen MB. Lack of guanylate cyclase C results in increased mortality in mice following liver injury. BMC Gastroenterol. 2010 Aug 2;10:86.
Marzioni M, Saccomanno S, Candelaresi C, Rychlicki C, Agostinelli L, Shanmukhappa K, Trozzi, L, Pierantonelli I, De Minicis S, Benedetti A. Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. J Hepatol. 2010 Oct;53(4):663-70.
Shanmukhappa K, Degen J, Bezerra J. Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem. 2009 May 8;284(19): 12917-12923.
Shanmukhappa K, Kim JK and Kapil S. Role of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection. Virol J. 2007; 4: 62.
Shanmukhappa K, Sabla GE, Degen JL, Bezerra JA. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterol. 2006 Nov 29;6:40.
Kim JK, Fahad AM, Shanmukhappa K, Kapil S. Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J Virol. 2006 Jan;80(2):689-96.
Rachel M. Sheridan, MD 513-636-4261 email@example.com
Pediatric pathology; liver pathology
MD: University Gama Filho, Rio de Janeiro, Brazil, 2000.
Residency: University of Cincinnati, Cincinnati, OH, 2004-2008.
Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2008-2010.
Cashman S, Lampe K, Sheridan R, Hoebe K. An ENU mutagenesis approach to dissect “self”-induced immune responses. OncoImmunology. 2012;1(6):1-7.
Sheridan RM, Stanek J, Khoury J, Handwerger S. Abnormal expression of transcription factor AP-2 alpha in pathologic placentas. Hum Pathol. 2012 May.
Sheridan RM, Gupta A, Miethke A, Knisely AS, Bove KE. Multiple dysplastic liver nodules in PFIC2 underscores risk for neoplasia associated with functional BSEP deficiency. Am J Surg Pathol. 2012;36(5):785-6.
Sheridan RM, Michelfelder EC, Choe KA, Divanovic A, Ware S, Liu C, Stanek JW. Ductus arteriosus aneurysm with massive thrombosis of the pulmonary artery. Pediatr Dev Pathol. 2012;15(1):79-85.
Sheridan R, Lampe K, Shanmukhappa SK, Putnam P, Keddache M, Divanovic S, Bezerra J, Hoebe K. Lampe1; an ENU germline mutant exhibiting spontaneous hepatosteatosis identified through targeted exon-enrichment and deep-sequencing. PLoS One. 2011;6(7):219-79.
Maugans T, Sheridan RM, Adams D, Gupta A. Cutaneous vascular anomalies associated with neural tube defects: nomenclature and pathology revisited. J Neurosurg. 2011;69(1):112-8.
Stanek J, Sheridan RM, Crombleholme T. Stasis-induced fetal vasculopathy in placentas from EXIT procedures. Placenta. 2011;32:373-9.
Yi Y, Mikhaylova O, Mamedova A, Bastola P, Biesiada J, Alshaikh E, Levin L, Sheridan RM, Meller J, Czyzyk-Krzeska MF. Von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas. Clin Cancer Res. 2010;16(21):5142-52.
Jerzy W. Stanek, MD, PhD 513-636-8158 firstname.lastname@example.org
Placental pathology; pathology of in-utero hypoxia
MD: College of Medicine, Jagiellonian University, Kraków, Poland, 1968.
PhD: College of Medicine, Jagiellonian University, Kraków, Poland, 1974.
Residencies: University Hospital of Obstetrics and Gynecology, Jagiellonian University, Kraków, Poland, 1970-1976; Georgetown University Medical Center, Washington, DC, and Rush Presbyterian-St.Luke's Medical Center, Chicago, IL, 1990-1994.
Fellowship: Reproductive Endocrinology, University Hospital of Obstetrics and Gynecology, Kraków, Poland; 1976-1977.
Certifications: Obstetrics and Gynecology, Polish Board of Obstetrics and Gynecology, 1976; Endocrinology, Postgraduate Medical Center, Poland, 1977; Anatomic and Clinical Pathology, American Board of Pathology, 1994; Pediatric Pathology, American Board of Pathology, 1999.
Kessler CA, Stanek JW, Stringer KF, Handwerger S. ETS1 induces human trophoblast differentiation. Endocrinology. 2015 Feb 2.
Sheridan R, Belludi C, Khoury J, Stanek J, Handwerger S. FOXO1 expression in villous trophoblast of preeclampsia and fetal growth restriction placentas. Histol Histopathol. 2015;30:213-222.
Stanek J. Placental hypoxic overlap lesions: A clinicoplacental correlation. J Obstet Gynaecol Res. 2015;41:358-369.
Stanek J, Biesiada J, Trzeszcz M. Clinicoplacental phenotypes vary with gestational age: An analysis by classical and clustering methods. Acta Obstet Gynecol Scand. 2014;93:392-398.
Calvo-Garcia MA, Lim FY, Stanek J, Bitters C, Kline-Fath BM. Congenital peribronchial myofibroblastic tumor: Prenatal imaging clues to differentiate from other fetal chest lesions. Pediatr Radiol. 2014;44:479-83.
Stanek J. Comparison of placental pathology in preterm, late-preterm, near-term, and term births. Am J Obstet Gynecol. 2014;210:234.e1-6.
Stanek J, Biesiada J. Relation of placental diagnosis in stillbirth to fetal maceration and gestational age at delivery. J Perinat Med. 2014;42:457-71.
Stanek J. Hypoxic patterns of placental injury: a review. Arch Pathol Lab Med. 2013;137:706-720.
Stanek J. Periarterial stem villous edema is associated with hypercoiled umbilical cord and stem obliterative endarteritis. OJOG. 2013;3(9A):9-14.
Stanek J, Biesiada J. Clustering of maternal/fetal clinical conditions and outcomes and placental lesions. Am J Obstet Gynecol. 2012;206:493.e1-8.
Paul E. Steele, MD Medical Director, Clinical Laboratory 513-636-4898 email@example.com
Medical Director, Clinical Laboratory
Paul E. Steele, MD, is medical director of the clinical laboratory at Cincinnati Children's Hospital Medical Center, arriving in 1999. He came to Cincinnati Children's Hospital Medical Center from University Hospital of Cincinnati, where he was a member of the laboratory medicine staff for 11 years.
Dr. Steele's background includes general laboratory directorship, as he was medical director of University Hospital's Immediate Response Laboratory for over two years before coming to Cincinnati Children's.
Dr. Steele has also served as medical director of Diagnostic Immunology since arriving at University Hospital. In this position, he was involved in humoral immunology, including infectious disease serology, autoimmune testing, protein characterization, and allergy testing; he was also involved in flow cytometry, including transplantation, stem cell and HIV monitoring, as well as evaluation and monitoring of hematopoietic neoplasms.
Dr. Steele has also been involved in molecular pathology. At University Hospital, he put in place a molecular diagnostics laboratory which provided molecular genetic detection of lymphoid clonality as well as chromosomal translocation in chronic myelocytic leukemia. At Cincinnati Children's Hospital Medical Center, he has become a participant in overseeing the molecular genetic testing for infectious disease.
Dr. Steele's research interests include the evaluation of human endogenous retroviral sequences and their role in human pathology. This work is an outgrowth of studies he began as a postdoctoral fellow at the National Institutes of Health.
Specifically, Dr. Steele has created antisera to a biosynthetic fusion protein containing a portion of a human endogenous retroviral envelope gene that encodes a putative immunosuppressive protein. This antisera detects a human protein which is the subject of Dr. Steele's study.
MD: University of Missouri, Kansas City, 1978.
Residency: Anatomic Pathology, Massachusetts General Hospital, Boston 1978-81; Clinical Pathology, Barnes Hospital, St. Louis, MO, 1984-86.
Fellowships: Basic science fellowship, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, 1981-84.
Certification: Anatomic and Clinical Pathology, 1987.
Keith F. Stringer, MD Pathologist, Division of Pathology and Laboratory Medicine 513-636-4261 firstname.lastname@example.org
Pathologist, Division of Pathology and Laboratory Medicine
Microscopic techniques for assessing mRNA expression; protein production and cellular identity in eukaryotic tissues; stem cell development and differentiation using animal models such as the zebrafish
BSc: University of British Columbia, Vancouver, British Columbia, Canada.
MSc: University of Toronto, Toronto, Ontario, Canada.
MD: University of Calgary, Calgary, Alberta, Canada, 1995.
DABP: Anatomic and Pediatric Pathology.
Xu YH, Jia L, Quinn B, Zamzow M, Stringer K, Aronow B, Sun Y, Zhang W, Setchell KD, Grabowski GA. Global gene expression profile progression in Gaucher disease mouse models. BMC Genomics. 2011 Jan 11;12:20.
Sivaprasad U, Askew DJ, Ericksen MB, Gibson AM, Stier MT, Brandt EB, Bass SA, Daines MO, Chakir J, Stringer KF, Wert SE, Whitsett JA, Le Cras TD, Wills-Karp M, Silverman GA, Khurana Hershey GK. A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. J Allergy Clin Immunol. 2011 Jan;127(1):254-61, 261.e1-6.
Shi Z, Dragin N, Miller ML, Stringer KF, Johansson E, Chen J, Uno S, Gonzalez FJ, Rubio CA, Nebert DW. Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer. 2010 Nov 15;127(10):2334-50.
Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer K, Putnam PE, Rothenberg ME. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol. 2010 Jul;126(1):140-9.
Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, Putnam PE, Abonia JP, Santos J, Rothenberg ME. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut. 2010 Jan;59(1):12-20.
Qi X, Chu Z, Mahller YY, Stringer KF, Witte DP, Cripe TP. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein. Clin Cancer Res. 2009 Sep 15;15(18):5840-51.
Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol. 2008 Nov 15;181(10):7390-9.
Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD, Rothenberg ME. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008 Jul;1(4):289-96.
Collins MH, Blanchard C, Abonia JP, Kirby C, Akers R, Wang N, Putnam PE, Jameson SC, Assa'ad AH, Konikoff MR, Stringer KF, Rothenberg ME. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol. 2008 Jun;6(6):621-9.
Shivakumar P, Sabla G, Mohanty S, McNeal M, Ward R, Stringer K, Caldwell C, Chougnet C, Bezerra JA. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology. 2007 Jul;133(1):268-77.
Peter H. Tang, PhD Director, Special Chemistry 513-636-3357 email@example.com
Director, Special Chemistry
In vitro diagnostics; disease monitoring procedures
PhD: Analytical Chemistry, University of Cincinnati, Cincinnati, OH, 1990.
MS: Biochemistry, Northeast Louisiana University, Monroe, LA, 1985.
BS: Pharmacy, Taipei Medical College, Taipei, Taiwan, 1978.
Graham DL, Grace CE, Braun AA, Schaefer TL, Skelton MR, Tang PH, Vorhees CV, Williams MT. Effects of developmental stress and lead (Pb) on corticosterone after chronic and acute stress, brain monoamines, and blood Pb levels in rats. Int J Dev Neurosci. 2011 Feb;29(1):45-55.
Miles MV, Putnam PE, Miles L, Tang PH, DeGrauw AJ, Wong BL, Horn PS, Foote HL, Rothenberg ME. Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies. Mitochondrion. 2011 Jan;11(1):127-35.
Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010 Sep;52(3):934-44.
Miles MV, Tang PH, Miles L, Steele PE, Moye MJ, Horn PS. Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets. Biomed Chromatogr. 2008 Dec;22(12):1403-8.
Tang PH. Drug monitoring and toxicology: a simple procedure for the monitoring of felbamate by HPLC-UV detection. J Anal Toxicol. 2008 Jun;32(5):373-8.
Herring NR, Schaefer TL, Tang PH, Skelton MR, Lucot JP, Gudelsky GA, Vorhees CV, Williams MT. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci. 2008 May 30;9:49.
Miles MV, Miles L, Tang PH, Horn PS, Steele PE, DeGrauw AJ, Wong BL, Bove KE. Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain enzyme deficiencies. Mitochondrion. 2008 Mar;8(2):170-80.
Miles MV, Patterson BJ, Chalfonte-Evans ML, Horn PS, Hickey FJ, Schapiro MB, Steele PE, Tang PH, Hotze SL. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol. 2007 Dec;37(6):398-403.
Tang PH, Miles MV, Steele P, Davidson BS, Geraghty SR, Morrow AL. Determination of coenzyme Q10 in human breast milk by high-performance liquid chromatography. Biomed Chromatogr. 2006 Dec;20(12):1336-43.
Tang PH. Determination of coenzyme Q10 in over-the-counter dietary supplements by high-performance liquid chromatography with coulometric detection. J AOAC Int. 2006 Jan-Feb;89(1):35-9.
Dehua Wang, MD Staff Pathologist, Department of Pathology 513-636-4261 firstname.lastname@example.org
Staff Pathologist, Department of Pathology
Pediatric pathology; hematopathology
MD: Tongji Medical University, Yunyang Medical College, Hubei, China.
Residency: Anatomic and Clinical Pathology, Drexel University College of Medicine, Philadelphia, PA, 2008-2009; Boston University Medical Center, Boston, MA, 2009-2012.
Fellowship: Hematopathology, Indiana University School of Medicine, Indianapolis, IN, 2013; Pediatric pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2014.
Certification: Anatomic and Clinical Pathology, 2012; Hematopathology, 2013.
Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multi-ethnic prenatal population. Am J Clin Pathol. 2010 Sep;134(3):438-42.
Wang D, Paz-Priel I, Friedman AD. NF-κ B p50 Regulates C/EBPα Expression and Inflammatory Cytokine-Induced Neutrophil Production. J Immunol. 2009 May 1;182(9):5757-62.
Cai DH, Wang D, Keefer J, Yeamans C, Hensley K, Friedman AD. C/EBPα:AP-1 Leucine Zipper Heterodimers Bind Novel DNA Elements, Activate the PU.1 Promoter, and Direct Monocyte Lineage Commitment More Potently Than C/EBPα Homodimers or AP-1. Oncogene. 2008 Apr 24;27(19):2772-9.
Yeamans C, Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman AD. C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood. 2007 Nov 1;110(9):3136-42.
Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007 Mar;14(3):500-10.
Wang D, D'Costa J, Civin CI, Friedman AD. C/EBPα directs monocytic commitment of primary myeloid progenitors. Blood. 2006 Aug 15;108(4):1223 –9.
Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalphamyeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Mol Cancer Res. 2005 Oct;3(10):585-96.
Wang D, McDonnell MA, Kelekar A. Multi-probe RPA template sets to study RNA modulation and transcriptional control of BH3-only members of the Bcl-2 family. Cancer Detect Prev. 2005;29(2):189-200.
McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A. Caspase-9 is activated in a cytochrome c-independent manner early during TNFα-induced apoptosis in murine cells. Cell Death Differ. 2003 Sep;10(9):1005 –15.
Wang D, Liao S, Gao Z. Mulivariate analysis of prognostic factors in non-small cell lung cancer. Zhonghua Yi Xue Za Zhi. 1997 Jul;77(7):497-500.
Kathryn A. Wikenheiser-Brokamp, MD, PhD Director, Residency Research Program 513-803-0239 email@example.com
Director, Residency Research Program
Associate Director, Medical Scientist Training Program
Associate Professor, UC Department of Pathology & Laboratory Medicine
Pathology; pulmonary pathology
BS: Mathematics/Natural Science, Secondary Education Minor, University of Mary, Bismarck, ND, 1988.
PhD: Developmental Biology, Developmental Biology and Medical Science Scholars Programs, University of Cincinnati, Cincinnati, OH, 1994.
MD: Medical Science Scholars Program, University of Cincinnati, Cincinnati, OH, 1996.
Residency: Anatomic Pathology, Department of Pathology and Immunology, Washington University-Barnes/Jewish Hospital, St. Louis, MO, 1996-2002.
Clinical Training/Postdoctoral Research: Department of Pathology and Immunology, Washington University, St. Louis, MO, 1999-2002.
Licensure: State of Ohio, 2003.
Certification: Anatomic Pathology, The American Board of Pathology, 1999.
Chlon TM, Hoskins EE, Mayhew CN, Wikenheiser-Brokamp KA, Davies SM, Mehta P, Myers KC, Wells JM, Wells SI. High-risk Human Papillomavirus E6 protein promotes reprogramming of Fanconi Anemia patient cells through repression of p53 but does not allow for sustained growth of induced Pluropotent Stem Cells. J Virol. 2014 Oct 1;88(19):11315-26.
Adams AK, Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, Wikenheiser-Brokamp KA, Wise-Draper TM, Wells SI. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Oncogene. 2-14 Mar 10;0:1.
Cundiff WB, McCormack FX, Wikenheiser-Brokamp K, Starnes S, Kotloff R, Benzaquen S. Successful management of a chronic, refractory bronchopleural fistula with endobronchial valves followed by talc pleurodesis. Am J Respir Crit Care Med. 2014 Feb 15;189(4):490-1.
Akeno N, Miller AL, Ma X, Wikenheiser-Brokamp KA. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene. 2014 Jan 27.
Zafar MA, McCormack FX, Rahman S, Tencza C, Wikenheiser-Brokamp KA, Young LR, Shizukuda Y, Elwing JM. Pulmonary vascular shunts in exercise-intolerant patients with lymphangioleiomyomatosis. Am J Respir Cri. Care Med. 2013 Nov 1;188(9):1167-70.
McCormack FX, Wilmott C, Young LR, Wikenheiser-Brokamp K. An atoll variant that mocks. Am J Respir Crit Care Med. 2013 Jul 1;188(1): 110.
Meraj R, Wikenheiser-Brokamp KA, Young LR, Byrnes S, McCormack FX. Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis. Front Med. 2012 Dec;6(4); 395-405.
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, Messenger Y, Goodfellow PJ. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009 Aug 21;325(5943):965.
Simpson DS, Mason-Richie NA, Gettler CA, Wikenheiser-Brokamp KA. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis. Cancer Res. 2009 Nov 15;69(22):8733-41.
Mason-Richie NA, Mistry MJ, Gettler CA Elayyadi A, Wikenheiser-Brokamp KA. Retinoblastoma function is essential for establishing lung epithelial quiescence after injury. Cancer Res. 2008 Jun 1;68(11):4068-76.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center